PLSE Operating Cash Flow (Statement)
Pulse Biosciences Inc · Operating Cash Flow (Statement)
PLSE Operating Cash Flow (Statement)
Latest reported-$61.10Mperiod ending
PLSE TTM Cash from Operations (-$3.32M → -$61.10M)
TTM operating cash flow (statement)
High-resolution chart · PNG
PLSE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -61,098,000 | |
| -55,196,000 | |
| -54,122,000 | |
| -48,511,000 | |
| -44,496,000 | |
| -40,084,000 | |
| -36,343,000 | |
| -33,975,000 | |
| -35,438,000 | |
| -36,245,000 | |
| -33,035,000 | |
| -34,224,000 | |
| -34,369,000 | |
| -37,989,000 | |
| -47,013,000 | |
| -51,742,000 | |
| -54,460,000 | |
| -58,004,000 | |
| -54,097,000 | |
| -50,658,000 | |
| -45,857,000 | |
| -37,430,000 | |
| -35,365,000 | |
| -35,306,000 | |
| -34,722,000 | |
| -36,477,000 | |
| -34,185,000 | |
| -31,297,000 | |
| -30,182,000 | |
| -26,208,000 | |
| -23,896,000 | |
| -21,551,000 | |
| -18,118,000 | |
| -13,606,000 | |
| -11,087,000 | |
| -9,442,000 | |
| -8,007,000 | |
| -9,088,000 | |
| -8,051,000 | |
| -7,062,768 | |
| -6,028,768 | |
| -4,321,768 | |
| -3,316,768 | |
| -2,161,177 |